Major vault protein (MVP) suppresses aging- and estrogen deficiency-related bone loss through Fas-mediated apoptosis in osteoclasts
Open Access
- 13 September 2023
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 14 (9) , 1-11
Abstract
Osteoclasts (OCs), derived from monocyte/macrophage lineage, are key orchestrators in bone remodeling. Targeting osteoclast apoptosis is a promising approach to cut down excessive osteoclast numbers, and thus slow down the rate of bone mass loss that inevitably occurs during aging. However, the therapeutic target of apoptosis in osteoclasts has not been fully studied. Our previous work generated Mvpf/fLyz2-Cre mice, conditionally depleting major vault protein (MVP) in monocyte lineage, and identified MVP as a bone protector for its negative role in osteoclastogenesis in vivo and in vitro. Here, we observed a notable decline of MVP in osteoclasts with aging in mice, encouraging us to further investigate the regulatory role of osteoclast MVP. Then, Mvpf/fLyz2-Cre mice were exploited in two osteoporosis contexts, aging and abrupt loss of estrogen, and we revealed that conditional knockout of MVP inhibited osteoclast apoptosis in vivo and in vitro. Moreover, we reported the interaction between MVP and death receptor Fas, and MVP-Fas signaling cascade was identified to positively regulate the apoptosis of osteoclasts, thus preventing osteoporosis. Collectively, our comprehensive discovery of MVP’s regulatory role in osteoclasts provides new insight into osteoclast biology and therapeutic targets for osteoporosis.Keywords
This publication has 41 references indexed in Scilit:
- Disorders of Bone RemodelingAnnual Review of Pathology: Mechanisms of Disease, 2011
- Targeting Fas in osteoresorptive disordersExpert Opinion on Therapeutic Targets, 2010
- From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of OsteoporosisEndocrine Reviews, 2010
- Targeting major vault protein in senescence-associated apoptosis resistanceExpert Opinion on Therapeutic Targets, 2009
- On the role of major vault protein in the resistance of senescent human diploid fibroblasts to apoptosisCell Death & Differentiation, 2008
- Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survivalThe EMBO Journal, 2008
- The molecular understanding of osteoclast differentiationBone, 2007
- Aging Increases Stromal/Osteoblastic Cell-Induced Osteoclastogenesis and Alters the Osteoclast Precursor Pool in the MouseJournal of Bone and Mineral Research, 2005
- Osteoclast differentiation and activationNature, 2003
- Changes in Bone Structure and Mass With Advancing Age in the Male C57BL/6J MouseJournal of Bone and Mineral Research, 2002